Niagen Bioscience Rebrands Research Program to Advance NAD+ Knowledge and Support Emerging Scientists

Niagen Bioscience (NAGE) enhances its commitment to scientific innovation through a comprehensive rebranding initiative. The company transitions from the ChromaDex External Research Program to the newly named Niagen Research Program, which positions its research efforts more closely with its patented Niagen ingredient. This strategic move reflects a dedicated focus on advancing knowledge around NAD+ and its implications for exercise performance and recovery.

Nutritional Research Aligned with Niagen's Strategic Goals

By fostering new talent through the Trainee Grant Program, Niagen Bioscience aims to enhance its competitive edge in the market. This initiative is pivotal in nurturing upcoming investigators and maintaining a robust pipeline of innovative research findings that could significantly impact the health and wellness industry focused on exercise performance and recovery.

Commitment to Advancing NAD+ Knowledge

The company extends its support to over 175 ongoing studies related to NAD+ across the globe, underscoring its commitment to advancing knowledge in this crucial area. As health and wellness trends increasingly hinge on the potential benefits of NAD+, Niagen strategically positions itself to lead in this emerging field, reinforcing its role as a key player in nutritional science and innovation.

Conclusion

Through this rebranding and dedicated support of emerging researchers, Niagen Bioscience not only strengthens its brand identity but also lays the groundwork for future innovations in health science. This proactive approach to R&D aligns the company with the evolving landscape of nutritional research, ultimately benefiting both the brand and the broader health community.